Robert H. Vonderheide, MD, DPhil
Director, Abramson Cancer Center
Cancer immunotherapy and translational research
Dr. Vonderheide is an internationally renowned cancer immunotherapy and translational research expert. Through a focus on novel immunotherapies for pancreatic cancer, melanoma and breast cancers, Dr. Vonderheide has mapped new models for speeding translational - or "bench to bedside" research.